Latest
Imetelstat May Benefit Patients With Lower Risk MDS
Gut Microbial Dysbiosis May Play Role in R-CHOP Response in DLBCL
MRD Assessment Improves Risk-Based Treatment in Patients With Pediatric ALL
CIRS-G Reveals Accelerated Aging, Early Death in Childhood Cancer Survivors
71 Percent of Mpox Cases Occurred in Large Central Urban Areas
Low Immunity Against COVID-19 Omicron Variants Despite 3 Vaccine Doses in Hematologic Malignancies
Impact on HRQOL Varies in Young Patients With Iron-Deficiency Anemia
Higher-Dose CS Increases Mortality in Patients With COVID-19 Using Simple Oxygen
More Mpox Cases Reported as Health Officials Fear a Summer Resurgence
More Older Americans Use Online Patient Portals to Access Care
Outcomes Appear Poor After CD19-Directed CAR-T Therapy Relapse in Children With B-ALL
Voxelotor Shows Efficacy in Children Aged 2 to 4 Years With SCD
Featured Content
ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.
Caring for the Caregivers of Patients With Hematologic Malignancies Undergoing HSCT
Researchers sought to address the needs of caregivers of patients with hematologic malignancies undergoing HSCT.
Weighing the Efficacy and Toxicity of CAR T-Cell Therapy
Researchers sought to determine the balance between the efficacy and toxicity when administering CAR T-cell therapy.
Disrupting the Status Quo: ACCESS Initiative Takes Aim at Inequities in HCT, Cellular Therapy
NMDP/Be The Match and the ASTCT seek to address inequities in HCT and cellular therapy.
- Loading...
Loading...
Loading... 
Loading...